Does gestrinone antagonize the effects of estrogen on endometrial implants upon the peritoneum of rats?

Clinics

Volumn 63, Issue 4, 2008, Pages 525-530

  Lobo, Vera Lúcia Rodrigues ^a   Soares Jr , José Maria ^a,b   De Jesus Simões, Manuel ^b   Simões, Ricardo Dos Santos ^a   De Lima, Geraldo Rodrigues ^a   Baracat, Edmund C ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Estrogen; Experimental endometriosis; Gestrinone; Ovariectomized rats; Peritoneal implants

Indexed keywords

ANTIESTROGEN; ESTROGEN; GESTAGEN; GESTRINONE;

ANIMAL; ARTICLE; DISEASE MODEL; DRUG SCREENING; ENDOMETRIOSIS; FEMALE; OVARIECTOMY; PATHOLOGY; RAT; WISTAR RAT;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; ENDOMETRIOSIS; ESTROGEN ANTAGONISTS; ESTROGENS; FEMALE; GESTRINONE; OVARIECTOMY; PROGESTINS; RATS; RATS, WISTAR;

EID: 50449110611     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322008000400019     Document Type: Article

References (37)

1. Wharton Jr LR Endometriosis. In: Mattingly, RF. Te Linde's Operative Gynecology. Philadelphia, J.B. Lippincott Company, 1977. p. 223-52.
2. Sampson JA. Heterotopic or misplaced endometrial tissue. Am. J. Obstet. Gynecol. 1925;10:649-64.
3. Taylor RN, Lebovic DI, Mueller MD. Angiogenic factors in endometriosis. Ann N Y Acad Sci. 2002;955:89-100.
4. Witz CA, Burns WN. Endometriosis and infertility: is there a cause and effect relationship? Gynecol Obstet Invest. 2002;53 Suppl 1:2-11.
5. Grümmer R.Animal models in endometriosis research.Hum Reprod Update. 2006;12:641-9.
6. Golan A, Winston RM, Dargenio R. Experimental endometriosis: a microsurgical animal model in rats.Isr J Med Sci. 1984;20:1094-6.
7. Rajkumar K, Schott PW, Simpson CW. The rat as an animal model for endometriosis to examine recurrence of ectopic endometrial tissue after regression.Fertil Steril. 1990;53:921-5.
8. Sharpe KL, Bertero MC, Vernon MW. Detection of a progesterone-induced secretory protein synthesized by the uteri but not the endometriotic implants of rats with induced endometriosis.Fertil Steril. 1991;55:403-10.
9. Cummings AM, Metcalf JL. Induction of endometriosis in mice: a new model sensitive to estrogen.Reprod Toxicol. 1995;9:233-8.
10. Rock JA, Prendergast RA, Bobbie D, Green WR, Parmley TH, Dubin NH. Intraocular endometrium in the rabbit as a model for endometriosis. Fertil Steril. 1993;59:232-5.
11. Vernon MW, Wilson EA. Studies on the surgical induction of endometriosis in the rat. Fertil Steril. 1985;44:684-94.
12. Schor E, Baracat EC, Simões MJ, Freitas V, Giannotti Filho O, Lima, GR. Effects of conjugated estrogens and progestogen in surgically induced endometriosis in oophorectomized rats. Clin Exp Obstet Gynecol. 1999;26:158-161.
13. Fang Z, Yang S, Lydon JP, DeMayo F, Tamura M, Gurates B, et al. Intact progesterone receptors are essential to counteract the proliferative effect of estradiol in a genetically engineered mouse model of endometriosis. Fertil Steril. 2004;82:673-8.
14. Kudoh M, Susaki Y, Ideyama Y, Nanya T, Mori M, Shikama H. Inhibitory effects of a novel aromatase inhibitor, YM511, on growth of endometrial explants and insulin-like growth factor-I gene expression in rats with experimental endometriosis. J Steroid Biochem Mol Biol. 1997;63:75-80.
15. Jones RC. The effect of a luteinizing hormone releasing hormone (LRH) agonist (Wy-40,972), levonorgestrel, danazol and ovariectomy on experimental endometriosis in the rat. Acta Endocrinol (Copenh) 1984;106:282-8.
16. Katsuki Y, Takano Y, Futamura Y, Shibutani Y, Aoki D, Udagawa Y, et al. Effects of dienogest, a synthetic steroid, on experimental endometriosis in rats.Eur J Endocrinol. 1998 Feb;138:216-26.
17. Sakata M, Terakawa N, Mizutani T, Tanizawa O, Matsumoto K, Terada N, et al. Effects of danazol, gonadotropin-releasing hormone agonist, and a combination of danazol and gonadotropin-releasing hormone agonist on experimental endometriosis. Am J Obstet Gynecol. 1990;163:1679-84.
18. Yao Z, Shen X, Capodanno I, Donnelly M, Fenyk-Melody J, Hausamann J, et al. Validation of rat endometriosis model by using raloxifene as a positive control for the evaluation of novel SERM compounds. J Invest Surg. 2005;18:177-83.
19. Galhardo CL, Soares JM Jr, Simões RS, Haidar MA, Rodrigues de Lima G, Baracat EC. Estrogen effects on the vaginal pH, flora and cytology in late postmenopause after a long period without hormone therapy. Clin Exp Obstet Gynecol. 2006;33:85-9.
20. Bonduki CE, Lourenço DM, Motta EL, Soares JM Jr, Haidar MA, Baracat EC. Effect of estrogen-progestin hormonal replacement therapy on blood coagulation and fibrinolysis in postmenopausal women. Clinics. 2007;62:553-60.
21. Taylor H, Guarnaccia M, Olive D. Alternative medical treatment for endometriosis. Semin Reprod Endocrinol 1997;15:285-90.
22. Giu Y, Huang S, Wu X. Effects of gestrinone on experimental endometriosis in rabbits. Zhonghua Fu Chan Ke Za Zhi. 1995;30:735-7.
23. Tamaya T, Wada K, Imai A, Mori H, Ban H. Rationale for frequency and dose of administration in gestrinone therapy for pelvic endometriosis in the experimental model of rabbit uterus. Gen Pharmacol. 1991;22:505-10.
24. Quereda F, Barroso J, Acién P. Individual and combined effects of triptoreline and gestrinone on experimental endometriosis in rats. Eur J Obstet Gynecol Reprod Biol. 1996;67:35-40.
25. Rossi AG, Soares JM Jr, Motta EL, Simões MJ, Oliveira-Filho RM, Haidar MA, et al. Metoclopramide-induced hyperprolactinemia affects mouse endometrial morphology. Gynecol Obstet Invest. 2002;54:185-90.
26. Mayes JS, Watson GH. Direct effects of sex steroid hormones on adipose tissues and obesity. Obes Rev. 2004;5:197-216.
27. Punnonen RK, Klemi PJ, Nikkanen V. Postmenopausal endometriosis. Eur J Obstet Gynecol Reprod Biol 1980;11:153-9.
28. Burger HG. Physiological principles of endocrine replacement: estrogen. Horm Res. 2001;56 Suppl 1:82-5.
29. Cotroneo MS, Lamartiniere CA Pharmacologic, but not dietary, genistein supports endometriosis in a rat model. Toxicol Sci. 2001;61:68-75.
30. Lobo RA, Whitehead MI. Is low-dose hormone replacement therapy for postmenopausal women efficacious and desirable? Climacteric. 2001;4:110-9.
31. Rebar RW, Trabal J, Mortola J. Low-dose esterified estrogens (0.3 mg/ day): long-term and short-term effects on menopausal symptoms and quality of life in postmenopausal women. Climacteric. 2000;3:176-82.
32. Halaska M, Raus K, Martan A, Voigt R. Hormone therapy and urogynecology. Ceska Gynekol. 1998;63:453-6.
33. Tamaya T, Wada K, Imai A, Mori H, Ban H. Rationale for frequency and dose of administration in gestrinone therapy for pelvic endometriosis in the experimental model of rabbit uterus. Gen Pharmacol. 1991;22:505-510.
34. Kadaba R, Simpson CW. Disparate effect of tamoxifen in rats with experimentally induced endometriosis. Endocrinology. 1990;126:3263-7.
35. De Leo V, Morgante G, La Marca A, Musacchio MC, Sorace M, Cavicchioli C, et al. A benefit-risk assessment of medical treatment for uterine leiomyomas. Drug Saf. 2002;25:759-79.
36. Shaw RW. A risk benefit assessment of drugs used in the treatment of endometriosis. Drug Saf. 1994;11:104-13.
37. Wingfield M, Healy DL. Endometriosis: medical therapy. Baillieres Clin Obstet Gynaecol. 1993;7:813-38.